Clenbuterol

Clenbuterol is a strong, long-lasting beta-2 adrenergic receptor agonist — in plain terms, a drug that relaxes and opens the airways (a bronchodilator) by switching on a type of receptor in the “fight or flight” nervous system. It is used legitimately to treat blocked airways in horses and, in some countries, asthma in people. But it is widely misused off-label (for purposes the drug was never officially approved for) to lose fat and “hold on to muscle.” It helps to be clear about what clenbuterol is and is not: it is not an anabolic-androgenic steroid, it does not act on the androgen (testosterone-type) receptor, it is not 17α-alkylated (a chemical tweak that lets some steroids survive being swallowed but stresses the liver), and it is not a peptide. It also has no esters (a steroid-formulation feature that slows a drug’s release). So the risks people often link to steroids — liver damage from that 17α-alkylation, lowered testosterone, breast tissue growth in men (gynecomastia), or masculinizing changes in women (virilization) — simply don’t apply here. Its real dangers are to the heart and the body’s chemistry. This page is educational and focused on reducing harm; it contains no doses, cycles, or sourcing information.

What it is

Clenbuterol (chemical name 1-(4-amino-3,5-dichlorophenyl)-2-(tert-butylamino)ethanol; CAS 37148-27-9) is a small-molecule, selective beta-2 adrenergic receptor agonist — meaning it mainly switches on the beta-2 type of adrenaline receptor. It is a sympathomimetic (a drug that mimics adrenaline), not a hormone and not a steroid. Its structure resembles natural adrenaline-type chemicals (catecholamines), but it resists the enzymes (COMT and MAO) that normally break those down quickly. That resistance is why it sticks around so long in the body — its elimination half-life (the time for the body to clear half of a dose) is roughly 25–39 hours, and its effects last a long time.

How it works: it latches onto beta-2 receptors and, through a signaling chain (the Gs protein activating an enzyme called adenylyl cyclase), raises a cell messenger called cyclic AMP. In the smooth muscle lining the airways and blood vessels, that signal makes the muscle relax, which opens the airways (bronchodilation). The “anabolic” or “repartitioning” effect that shows up strongly in animals — more lean muscle, less fat — comes from beta-2 receptors on muscle and fat tissue. The exact steps after that aren’t fully worked out, but they are not driven by the androgen (testosterone) receptor. Clenbuterol is well absorbed when swallowed (about 70–80% of an oral dose makes it into the body).

The claims

In bodybuilding, athletic, and “biohacking” circles, clenbuterol is pushed off-label for fat loss, lower body fat, and keeping muscle while eating at a calorie deficit (eating fewer calories than you burn). It’s especially popular with women, precisely because it doesn’t cause the masculinizing effects (virilization) that anabolic steroids can. In livestock, it has been used illegally as a growth promoter to bulk up lean meat — a use that is banned in the US and EU and has poisoned people through contaminated meat.

Its genuine, evidence-backed uses are much narrower: opening the airways in horses with airway obstruction (the use the FDA actually approved, for veterinary medicine), and asthma or airway obstruction in some countries that license it for human breathing problems.

What the evidence actually shows

The human evidence on muscle and strength is small, old, and comes from clinical rehabilitation settings — not from trials in athletes.

• Orthopedic strength recovery (Maltin et al., 1993, Clin Sci (Lond) 84(6):651–654; PMID 8334811): This was a high-quality study (double-blind, randomized, placebo-controlled — meaning neither patients nor researchers knew who got the real drug, and a dummy treatment was used for comparison) in 20 healthy men recovering from knee surgery (open medial meniscectomy). It found that clenbuterol was linked to faster recovery of relative knee-extension strength in the operated leg. The authors called this “therapeutic potential” for muscle-wasting conditions — an early, promising hint, not proof of performance enhancement.
• Denervation atrophy (Jiang et al., 2011, Int Sch Res Notices/ISRN; PMID 22389867 / PMC3263717): This randomized, double-blind, placebo-controlled trial in 71 patients with a nerve injury (brachial plexus injury) found that clenbuterol meaningfully slowed the shrinking of both type I and type II muscle fibers (the slow-twitch and fast-twitch kinds) over three months. Again, this is a specific medical situation involving muscle wasting — not healthy people trying to gain.

Most claims that it boosts performance are borrowed from animal studies, where clenbuterol reliably adds muscle and cuts fat (“repartitioning”). Strong (8–10) trials showing real strength, performance, or body-composition gains in healthy athletes simply don’t exist. A wide-ranging review of WADA-banned substances (Heuberger & Cohen, Sports Medicine, 2018; PMC6422964) concluded that only a minority of banned drug classes have human evidence of genuinely improving performance; its look at beta-2 agonists focused mainly on inhaled drugs (salbutamol and terbutaline) rather than clenbuterol itself. Worth noting: the same animal studies that show repartitioning also show clenbuterol can cause an enlarged heart (cardiac hypertrophy) and heart-muscle cell death (myocyte necrosis) — which should cool any enthusiasm.

Legal and regulatory status

US — never FDA-approved for humans. The FDA has never approved clenbuterol for human use under the FD&C Act (the main federal food and drug law). So any product sold for people to take is an unapproved, misbranded drug; importing or selling clenbuterol for human use is illegal, and most US supply comes from illegal importation. The only legitimate source is veterinary, by prescription — Ventipulmin (clenbuterol HCl) Syrup, approved 11 May 1998 for airway obstruction in horses. Using it to fatten up livestock is illegal in the US and EU.

Not a controlled substance. Clenbuterol is not scheduled under the federal Controlled Substances Act (according to the DEA’s Diversion Control). That’s an important difference from anabolic-androgenic steroids, which are Schedule III drugs under the Anabolic Steroid Control Act of 1990 (effective 1991), later expanded by the Anabolic Steroid Control Act of 2004 and the Designer Anabolic Steroid Control Act of 2014 (DASCA). Clenbuterol is not a steroid, so it doesn’t fall under those laws. (For another point of contrast, human growth hormone has its own separate criminal law — handing it out for non-approved human uses is banned under 21 U.S.C. § 333(e).)

Anti-doping (WADA 2026). Clenbuterol is named directly under category S1 ANABOLIC AGENTS, in subsection S1.2 “Other Anabolic Agents,” alongside ractopamine, zilpaterol, zeranol, osilodrostat, and SARMs. S1 substances are banned at all times — both in and out of competition — and are non-Specified Substances (a stricter category, where an accidental positive is harder to explain away). It sits in S1.2 rather than S3 (Beta-2 Agonists) because of its muscle-building/repartitioning profile — unlike inhaled beta-2 agonists such as salbutamol and formoterol, which sit in S3 with allowed thresholds for inhaler use that clenbuterol does not get. (Human growth hormone and chorionic gonadotrophin fall under S2, also banned at all times.) There is no allowed therapeutic threshold for clenbuterol. That said, WADA’s Stakeholder Notice on meat contamination says that a result at or below 5 ng/mL is first reported as an Atypical Finding and checked for a possible contaminated-meat cause before it’s treated as a true doping violation (an Adverse Analytical Finding) — recognizing that low-level positives can come from eating tainted meat in some parts of the world.

Safety

Clenbuterol’s side effects come from overstimulating the adrenaline (beta-adrenergic) system, and its long half-life makes things worse — the symptoms of an overdose can drag on for many hours.

• Cardiovascular (the main danger): a fast heart rate (tachycardia), pounding heartbeat (palpitations), and irregular rhythms (arrhythmias, including supraventricular tachycardia and reported atrial fibrillation), high blood pressure or a rebound drop in blood pressure (reflex hypotension), chest pain, and damage to the heart muscle. Overdose and poisoning reports describe rapid abnormal rhythms (tachyarrhythmia), low blood potassium (hypokalemia), high blood sugar (hyperglycemia), a buildup of acid in the blood (lactic acidosis), and raised blood markers of heart injury; treating it can mean hospital care, beta-blocker drugs, and replacing lost potassium. Animal studies show clenbuterol can cause an enlarged heart (cardiac hypertrophy) and death of heart-muscle cells (myocyte necrosis).
• Metabolic / electrolyte: beta-2 stimulation pushes potassium out of the bloodstream and into cells, causing low blood potassium (hypokalemia) — which itself raises the risk of dangerous heart rhythms — along with high blood sugar (hyperglycemia) and lactic acidosis (acid buildup in the blood).
• Neuromuscular / nervous system: muscle shakiness (tremor), jitteriness and anxiety, headache, trouble sleeping, dizziness, and sweating; nausea and vomiting in cases of poisoning.
• Contaminated-meat poisonings: eating meat or liver tainted with clenbuterol (from its illegal use in livestock) has caused documented human outbreaks — Spain (1990, roughly 135 cases from veal liver), China (Shanghai 2006, around 336 hospitalized; Guangdong 2009), and Italy. Symptoms usually start about 0.5–6 hours after eating and clear over roughly 2–6 days.
• What does NOT apply to clenbuterol: liver damage from 17α-alkylation, suppression of the body’s own hormone system (HPTA suppression) and infertility, breast growth in men (gynecomastia), masculinizing changes (virilization), and thickened blood from too many red cells (polycythemia/elevated hematocrit) are side effects of anabolic steroids, not clenbuterol. Clenbuterol doesn’t act on androgen receptors or the reproductive hormone axis (the HPG axis), and it isn’t 17-alkylated, so it doesn’t cause these. (In fact, the absence of virilization is exactly why it appeals to female users.) Those harms belong to anabolic steroids.

Bottom line

Clenbuterol is a long-acting beta-2 agonist — not a steroid and not a peptide. The human evidence that it preserves muscle is limited to small, old rehabilitation trials (after surgery and in nerve-injury muscle wasting), and the flashier fat-loss and muscle-keeping claims rest mostly on animal data — there are no rigorous human trials showing it helps healthy athletes. It has never been FDA-approved for human use (in the US it’s a veterinary-only prescription drug), it is not a controlled substance, and it is banned in sport at all times as an anabolic agent under WADA S1.2. Its real risks are to the heart and the body’s chemistry — irregular heart rhythms, low potassium, and documented poisonings — all made worse by how long it lingers in the body.

Evidence grade: 7/10 · Moderate.

Sources

• DEA Diversion Control — Clenbuterol drug & chemical evaluation fact sheet
• DEA Diversion Control — Anabolic Steroids fact sheet (Schedule III contrast)
• FDA / Ventipulmin (clenbuterol HCl) Syrup veterinary label — DailyMed
• Maltin CA et al., 1993 — clenbuterol increases relative muscle strength in orthopaedic patients, Clin Sci (Lond) (PMID 8334811)
• Jiang et al., 2011 — RCT of clenbuterol in denervated muscle atrophy, Int Sch Res Notices (PMID 22389867 / PMC3263717)
• Heuberger JAAC & Cohen AF, 2018 — Review of WADA Prohibited Substances, Sports Medicine (PMC6422964)
• WADA — The 2026 Prohibited List (clenbuterol under S1.2 Other Anabolic Agents; in force 1 Jan 2026)
• WADA — Prohibited List landing page
• WADA — Stakeholder Notice on meat contamination (≤5 ng/mL Atypical Finding handling)
• WADA — Statement on clenbuterol
• Case report and review of clenbuterol cardiac toxicity (PMID 30546764)
• Pediatric clenbuterol ingestion / toxicity review, Journal of Forensic and Legal Medicine
• 21 U.S.C. § 333(e) — HGH distribution criminal statute (contrast)